RxDoctor Payments Data

John Krebsbach, DPM

Podiatrist · Franklin, WINPI 1598704793

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,776 of the $5,676 with a category attached, or 84.1%. 19 manufacturers reported payments, led by Stryker at 31.0% of the total.

$5,676in general payments, 2019–2025

Across 63 payments — averaging $90.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Integra Lifesciences Corporation$905
  • Relja Innovations Inc$900
  • Aroa Biosurgery Incorporated$287
  • Sanara Medtech Inc.$251
  • Acera Surgical, Inc.$239
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$90016%
  • Food & beverage$4,77684%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,676 in reported general payments places this provider in the 85th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$85,224
Medicare patients
411
Services billed
1,733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate34$909
Ketoconazole36$885
Terbinafine Hcl74$811
Doxycycline Monohydrate21$432
Allopurinol31$431
Diclofenac Sodium17$339
Oxycodone Hcl23$215
Ciprofloxacin Hcl11$126
NystopNystatin22$119

Paid to pharmacies, not to this prescriber.

Other podiatrist in Franklin

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →